Drug intelligence / Profile preview

depigmented polymerized olea europaea pollen extract

Development stage
Phase 3
Lead developer
Leti Pharma
Administration
Subcutaneous
01

Overview

Depigmented polymerized olea europaea pollen extract is an allergen immunotherapy preparation manufactured from the pollen of the olive tree (*Olea europaea*). The extract undergoes a process of depigmentation (typically using mild acid under controlled conditions and dialysis) and subsequent polymerization with glutaraldehyde. This creates high molecular weight allergen polymers (allergoids) with reduced allergenicity in vivo while retaining immunogenicity needed to induce tolerance. The main mechanism is inducing immune tolerance to olive pollen allergens (notably Ole e 1), used to treat allergic rhinitis and/or asthma due to sensitization to olive pollen. This modified extract allows administration of higher doses with lower risk of systemic reactions compared to native or depigmented non-polymerized extracts, facilitating shorter up-titration protocols for subcutaneous immunotherapy[1][3].

Brand names
Depigoid
Other names
depigmented glutaraldehyde polymerized olea europaea pollen extractolea europaea polymerized allergoiddepigmented allergen extract of olive pollen

Beyond the preview

Go deeper on depigmented polymerized olea europaea pollen extract.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on depigmented polymerized olea europaea pollen extract.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call